BioVie Inc.
BIVI
$1.71
-$0.04-2.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.57M | 8.87M | 9.26M | 8.98M | 8.85M |
| Depreciation & Amortization | 229.20K | 229.20K | 229.20K | 229.20K | 229.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.07M | 19.19M | 23.94M | 25.43M | 32.18M |
| Operating Income | -18.07M | -19.19M | -23.94M | -25.43M | -32.18M |
| Income Before Tax | -17.54M | -18.99M | -24.27M | -25.56M | -32.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.54 | -18.99 | -24.27 | -25.56 | -32.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.54M | -18.99M | -24.27M | -25.56M | -32.12M |
| EBIT | -18.07M | -19.19M | -23.94M | -25.43M | -32.18M |
| EBITDA | -17.84M | -18.96M | -23.71M | -25.20M | -31.95M |
| EPS Basic | -14.94 | -21.14 | -39.62 | -57.08 | -79.24 |
| Normalized Basic EPS | -9.00 | -12.88 | -23.19 | -34.12 | -48.29 |
| EPS Diluted | -14.98 | -21.19 | -39.68 | -57.09 | -79.29 |
| Normalized Diluted EPS | -9.00 | -12.88 | -23.19 | -34.12 | -48.29 |
| Average Basic Shares Outstanding | 5.92M | 4.67M | 3.27M | 2.08M | 1.81M |
| Average Diluted Shares Outstanding | 5.92M | 4.67M | 3.27M | 2.08M | 1.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |